These CEO's of speculative biotechs on the ASX love to throw around huge global billion dollar revenue projection numbers for the sector in presentations ?
Timelines seem to have been extended once again (sadly) so the only thing that will turn this ship around in the interim looks to be a license / partnership deal and of course they have subtly dropped one of our platforms from the presentation if you compare the AGM presentation with today's - B Cell Immunotherapy
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.3¢ | $255.7K | 18.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 18692454 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4515891 | 5 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |